Hypoglycaemia News and Research

RSS

DAPA-CKD trial shows dapagliflozin reduces risk of chronic kidney disease

Dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalization and all-cause mortality in chronic kidney disease patients with or without type 2 diabetes.

31 Aug 2020

Applying "temporal pressure" to the skin can help deliver more drugs

Scientists from Nanyang Technological University, Singapore (NTU Singapore) and the Agency for Science, Technology and Research (A*STAR) have showed that applying "temporal pressure" to the skin of mice can create a new way to deliver drugs.

4 Aug 2020

Study explores the prevalence and underlying belief patterns associated with Drunkorexia

Mojito, appletini or a simple glass of fizz - they may take the edge off a busy day, but if you find yourself bingeing on more than a few, you could be putting your physical and mental health at risk according new research at the University of South Australia.

15 May 2020

Using digital data and AI to improve quality of life for people with diabetes

Until now, medical doctors have used biomarkers to determine the health status of people with diabetes (PWDs).

14 Nov 2019

Light sensitive insulin secreting switches to help diabetics in blood sugar control

Researchers from Tufts University devised a novel experiment wherein they engineered beta cells of the pancreas and transplanted these cells onto the pancreas of diabetic mice. This resulted in two to three times insulin production by the diabetic mice that helped them control their blood sugar. These transplanted cells could be controlled using light exposure explained scientists, making this a path breaking study for diabetics.

4 Nov 2019

New discovery paves way for better treatment of diabetes

Insulin, a hormone essential for regulating blood sugar and lipids, is normally produced by pancreatic β cells. In many people with diabetes, however, pancreatic cells are not (or no longer) functional, causing a chronic and potentially fatal insulin deficiency that can only be controlled through daily insulin injections.

16 Oct 2019

Newly tested medical device mimics the effects of traditional bariatric surgery in rodents

New research from King's College London published in EBioMedicine, has found that a newly tested medical device, called Sleeveballoon, mimics the effects of traditional bariatric surgery in rodents and produces impressive results on body weight, fatty liver and diabetes control.

11 Oct 2019

Preventing hypoglycaemia in diabetic patients could dramatically reduce hospital stays

Preventing in-patients with diabetes from developing hypoglycaemia could dramatically reduce the length of time they spend in hospital - according to new research from the University of East Anglia and Cambridge University Hospitals NHS Foundation Trust.

2 Oct 2019

Diabetes drug can also be used to treat heart failure

Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.

19 Sep 2019

Keto diet - for the military, aging and epilepsy

Ketogenic diet or keto diet has been in the news as a trending diet option for weight watchers and those who wish to lose those extra pounds.

17 Apr 2019

Best trained alert dogs have potential to improve Type 1 diabetes patients' quality of life

New research by the University of Bristol in collaboration with Medical Detection Dogs has found that the best trained alert dogs have the potential to vastly improve the quality of life of people living with Type 1 diabetes.

16 Jan 2019

New glucose binding molecule could be key to better metabolic control for diabetics

Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.

19 Nov 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.

3 Oct 2018

One in five diabetes inpatients experienced hypoglycemia during hospital stay

Diabetes UK is urging healthcare professionals to be hypo-aware for Hypo-awareness Week (24th- 30th September). The charity wants to raise awareness about hypoglycemia and is encouraging healthcare professionals working in hospitals to look out for the signs of hypoglycemia and ensure those at high risk are given the necessary support.

25 Sep 2018

IQWiG recommends update in health care aspects of DMP ‘type 1 diabetes’

Disease management programmes should be regularly updated to adapt them to the current state of medical knowledge.

25 Sep 2018

Study demonstrates cardiovascular safety of weight loss drug

A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI 61 trial presented today in a Hot Line Session at ESC Congress and published in the New England Journal of Medicine.

27 Aug 2018

Pregnant women with type 1 diabetes at increased risk of having babies with heart defects

Pregnant women with type 1 diabetes run a higher risk of having babies with heart defects, especially women with high blood glucose levels during early pregnancy, a study from Karolinska Institutet and the Sahlgrenska Academy in Sweden published in The BMJ shows.

5 Jul 2018

Dexcom receives CE Marking for new G6 continuous glucose monitoring system

Dexcom, Inc., a leader in continuous glucose monitoring, announced today that the company has received CE Mark for its Dexcom G6 System for people with diabetes ages two years and up.

12 Jun 2018

New research reveals links between type 1 diabetes and mental health

New research co-authored by Professor Stephanie Amiel, RD Lawrence Professor of Diabetic Medicine, and published in Diabetologia identifies key areas of the brain that change patients' ability to recognize hypoglycemia.

24 May 2018